G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan · Delayed Price · Currency is TWD 50.80
-0.40 (-0.78%)
Sep 17, 2025, 1:27 PM CST
G&E Herbal Biotechnology Market Cap
G&E Herbal Biotechnology has a market cap or net worth of 3.00 billion as of September 17, 2025. Its market cap has decreased by -6.79% in one year.
Market Cap
3.00B
Enterprise Value
2.55B
Revenue
294.26M
Ranking
n/a
PE Ratio
24.06
Stock Price
50.80
Market Cap Chart
Since April 28, 2008, G&E Herbal Biotechnology's market cap has increased from 2.62B to 3.00B, an increase of 14.44%. That is a compound annual growth rate of 0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 3.00B | -10.25% |
| Dec 31, 2024 | 3.34B | -2.92% |
| Dec 29, 2023 | 3.44B | 15.73% |
| Dec 30, 2022 | 2.97B | 90.71% |
| Dec 30, 2021 | 1.56B | -19.66% |
| Dec 31, 2020 | 1.94B | -3.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 307.10B |
| PharmaEssentia | 178.82B |
| Bora Pharmaceuticals Co., LTD. | 86.38B |
| Lumosa Therapeutics | 53.57B |
| Lotus Pharmaceutical | 49.05B |
| Oneness Biotech | 32.86B |
| Polaris Group | 29.01B |
| Center Laboratories | 27.60B |